The Effects of Fenugreek Extract (Fenobet) on Metabolic Syndrome

Tehran University of Medical Sciences

Status: Not yet enrolling

Conditions: Complementary Therapies; Diabetes Mellitus, Type 2; Metabolic Syndrome

Treatments: Dietary Supplement: Fenobet; Dietary Supplement: Placebo

Study type: Interventional

Funder types: Other

Identifiers

NCT06114134

97-1151

Details and patient eligibility

About

The current study is a three-blind, randomized clinical trial study that will be conducted on 60 people with metabolic syndrome. The eligible participants were allocated randomly to one of the two study groups (Fenobet, Placebo). Then, the eligible people were in one of two groups 1) receiving fenugreek extract, 2), receiving placebos and were examined for 8 weeks. At baseline and after two months of intervention, biochemical parameters, and anthropometric indices will be measured.

Full description

The current study is a three-blind, randomized clinical trial study that will be conducted on 60 people with metabolic syndrome. According to the ATP criteria, a person who has at least 3 of the following 5 components was considered as metabolic syndrome.

After providing the necessary information about the study to patients, written informed consent will be obtained from eligible volunteers.

Inclusion criteria:

• People with metabolic syndrome
• Fasting sugar above 100 mg/dL
• Both men and women
• Age range 20-60 years Exclusion criteria
• Injection of insulin or liraglutide
• People under 20 years old and over 60 years old
• having chronic cardiovascular diseases, chronic liver and kidney diseases, uncontrolled thyroid disorders and malignancies including cancer
• Taking herbal medicines or herbs to control blood sugar and fat in the last 6 months
• Patients who are treated with a special diet such as vegetarianism or a special exercise program.
• Allergy
• Pregnant and lactating women The participants were allocated randomly to one of the two study groups (Fenobet, Placebo) by a random number table. Then, the eligible people were in one of two groups 1) receiving fenugreek extract (3 capsules of 500 mg, 1 capsule half an hour before meals), 2), receiving placebos (3 capsules of 500 mg, 1 capsule half an hour before meals) and were examined for 8 weeks. It is worth noting that the participants were asked not to change their physical activity and diet during the study and to report any changes in the type and dosage of the drug to the researchers. The capsule and container intended for the placebo will be exactly the same size and color as the fenugreek capsule and a dark container will be chosen for the capsules. At baseline and after two months of intervention, biochemical parameters (fasting blood sugar, HbA1C, lipid profile, C-reactive protein), and anthropometric indices (weight, body mass index, waist circumference, Hip circumference) will be measured.

Enrollment: 60 estimated patients

Sex: All

Ages: 20 to 60 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

People with metabolic syndrome

• Fasting sugar above 100 mg/dL
• Both men and women
• Age range 20-60 years

Exclusion criteria

• Injection of insulin or liraglutide
• People under 20 years old and over 60 years old
• having chronic cardiovascular diseases, chronic liver and kidney diseases, uncontrolled thyroid disorders and malignancies including cancer
• Taking herbal medicines or herbs to control blood sugar and fat in the last 6 months
• Patients who are treated with a special diet such as vegetarianism or a special exercise program.
• Allergy
• Pregnant and lactating women

Trial design

Primary purpose: Other

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

60 participants in 2 patient groups, including a placebo group

Fenugreek extract

Experimental group

Description:

Participants in this group will receive fenugreek extract capsules (500 mg/day, three times a day, 30 minutes before each main meal) along with common treatments

Treatment:

Dietary Supplement: Fenobet

Placebo

Placebo Comparator group

Description:

Participants in this group will receive starch with added color (similar to the color of fenugreek extract) capsules (with the same size and color of fenugreek) (500 mg/day, three times a day, 30 minutes before each main meal) along with common treatments

Treatment:

Dietary Supplement: Placebo